BOLT Stock Catalyst: Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Private Placement

Oct 23, 2026 · 9:55am ET

Funds to advance PRA-216 in multiple high-value inflammatory indications.

Max move

+71.0%

High of day $7.55

Sparker timei

9:55am ET

BOLT · Oct 23, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Bolt Biotherapeutics, Inc. (Nasdaq: BOLT) announced the acquisition of Prana Therapies and a concurrent private placement of $120 million. The funds will be used to advance PRA-216 in multiple high-value inflammatory indications.

The acquisition and private placement were announced together, with the $120 million earmarked specifically for the development of PRA-216.

Bolt Biotherapeutics has a free float of 1,436,280 shares and 1,926,345 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time BOLT sparks.

Download Sniper App →

Catch the next BOLT-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

BOLT Stock Catalyst: Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Private Placement

BOLT · Oct 23, 2026

BOLT · Oct 23, 2026

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.